X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13) 13
humans (12) 12
middle aged (11) 11
type 2 diabetes (11) 11
uracil - analogs & derivatives (11) 11
diabetes (10) 10
diabetes mellitus, type 2 - drug therapy (10) 10
male (10) 10
aged (9) 9
double-blind method (9) 9
female (9) 9
hypoglycemic agents - therapeutic use (8) 8
piperidines - therapeutic use (8) 8
uracil - therapeutic use (8) 8
piperidines - adverse effects (7) 7
uracil - adverse effects (7) 7
adult (6) 6
alogliptin (6) 6
dipeptidyl-peptidase iv inhibitors - adverse effects (6) 6
internal medicine (6) 6
treatment outcome (6) 6
cardiac & cardiovascular systems (5) 5
care and treatment (5) 5
damage (5) 5
dipeptidyl-peptidase iv inhibitors - therapeutic use (5) 5
endocrinology & metabolism (5) 5
heart failure (5) 5
mellitus (5) 5
risk factors (5) 5
analysis (4) 4
complications and side effects (4) 4
double-blind (4) 4
drug therapy (4) 4
efficacy (4) 4
materials science, multidisciplinary (4) 4
mechanics (4) 4
model (4) 4
monotherapy (4) 4
research (4) 4
risk (4) 4
thiazolidinediones - therapeutic use (4) 4
vildagliptin (4) 4
abridged index medicus (3) 3
acute coronary syndrome (3) 3
acute coronary syndromes (3) 3
adolescent (3) 3
aged, 80 and over (3) 3
algorithms (3) 3
cardiovascular diseases (3) 3
diabetes mellitus, type 2 - blood (3) 3
diabetes mellitus, type 2 - complications (3) 3
dipeptidyl peptidase-4 inhibitor (3) 3
dose-response relationship, drug (3) 3
emerging treatments and technologies (3) 3
exhibitions (3) 3
heart attacks (3) 3
hyperglycemia (3) 3
hypoglycemic agents - adverse effects (3) 3
medicine, general & internal (3) 3
studies (3) 3
angina pectoris (2) 2
art, modern (2) 2
assessments (2) 2
association (2) 2
biological markers (2) 2
biomarkers (2) 2
blood glucose - drug effects (2) 2
blood-glucose control (2) 2
bridge (2) 2
cardiovascular (2) 2
cardiovascular disease (2) 2
cardiovascular diseases - mortality (2) 2
clinical trials (2) 2
clinical-trials (2) 2
coatings (2) 2
complications (2) 2
conceptual art (2) 2
coronary heart disease (2) 2
creep (2) 2
criticism and interpretation (2) 2
dekker, thomas (2) 2
diabetes therapy (2) 2
dipeptidyl-peptidase iv inhibitors - pharmacokinetics (2) 2
dipeptidyl-peptidase iv inhibitors - pharmacology (2) 2
disease (2) 2
dpp-4 inhibitors (2) 2
drug dosages (2) 2
drug therapy, combination (2) 2
drug-naive patients (2) 2
engineering, mechanical (2) 2
english literature (2) 2
flexibility based approach (2) 2
genetic algorithms (2) 2
germany (2) 2
glucagon-like peptide-1 (2) 2
glucose control (2) 2
glycated hemoglobin a (2) 2
glycated hemoglobin a - metabolism (2) 2
glycemic control (2) 2
health risk assessment (2) 2
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
UofT at Scarborough - Stacks (3) 3
Gerstein Science - Stacks (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
UofT at Mississauga - Stacks (2) 2
Art - Library use only (1) 1
UTL at Downsview - May be requested (1) 1
Victoria University Emmanuel College - Birge Storage (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9982, pp. 2067 - 2076
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1327 - 1335
Alogliptin, a new antihyperglycemic agent of the DPP-4 class, was shown to have no significant effect on cardiovascular risk over a median treatment period of... 
INHIBITOR ALOGLIPTIN | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | CLINICAL-TRIALS | VASCULAR OUTCOMES | RISK | COMPLICATIONS | THERAPIES | CARDIOVASCULAR SAFETY | MELLITUS | BLOOD-GLUCOSE CONTROL | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Uracil - therapeutic use | Male | Myocardial Infarction - complications | Myocardial Infarction - drug therapy | Uracil - adverse effects | Angina, Unstable - drug therapy | Piperidines - therapeutic use | Angina, Unstable - complications | Piperidines - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Uracil - analogs & derivatives | Type 2 diabetes | Care and treatment | Acute coronary syndrome | Patient outcomes | Risk factors | Myocardial infarction | Heart attacks | Cardiovascular disease | Angina | Drug development | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Drug dosages | Cerebral infarction | Stroke | Peptidase | Statistical analysis | Diabetes mellitus | Pancreatitis | Committees | FDA approval | Hypoglycemia | Angina pectoris | Studies | Product development | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Diabetes Care, ISSN 0149-5992, 12/2008, Volume 31, Issue 12, p. 2315
Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Alogliptin in Patients With Type 2 Diabetes and Inadequate Glycemic Control A randomized,... 
Journal Article
Current Medical Research and Opinion, ISSN 0300-7995, 10/2009, Volume 25, Issue 10, pp. 2361 - 2371
Journal Article
Journal of the American Geriatrics Society, ISSN 0002-8614, 11/2009, Volume 57, Issue 11, pp. 2011 - 2019
Journal Article
Journal of the American Geriatrics Society, ISSN 0002-8614, 11/2009, Volume 57, Issue 11, pp. 2011 - 2019
Journal Article